Abbott reinforces commitment towards holistic diabetes care through new collaborations

National: Abbott announced new collaborations with key health-tech partners BeatO, Sugar.fit, PharmEasy, GOQii, 1MG, Zyla Health, Healthifyme and Fitterfly to usher a new era of holistic diabetes management care. Through these collaborations, Abbott aims to offer glucose monitoring solutions to eight million people living with diabetes, of which approximately 6.5M users can access through PharmEasy and 1MG. The company is focused on maintaining effective glucose level along with remote consultations, diabetes-specific coaching, and dietary plans.

Through these collaborations, Abbott endeavours to enable personalised lifestyle and therapy interventions, so people with diabetes can achieve holistic glucose management goals.

Kalyan Sattaru, General Manager, Diabetes Care Business, Abbott, said, “Continued research and strategic partnerships have simplified and strengthened diabetes management over the years. New diabetes technology has paved the way for precise and informed decision making. Connecting our partner brands’ products with the FreeStyle Libre portfolio will enable users to capture their glucose data easily as part of an integrated system.”

Gautam Chopra, Co-founder, CEO, BeatO commented, “Leveraging Abbott’s FreeStyle Libre with BeatO’s app ecosystem will give our users precise data, along with actionable insights to effectively manage and control blood glucose levels. We are continuously striving to make diabetes management more effective and convenient for our members and this programme is a step in the same direction.”

Madan Somasundaram, Co-founder, CEO, Sugar.fit said, "At Sugar.fit, our mission is to empower people with chronic conditions to live better and healthier lives and reverse chronic metabolic disorders. Technology is combined with science and human coaching to help millions of Indians manage and reverse diabetes through a highly consumer-centric data-driven digital health experience.”